09
Jan
New Delhi [India], January 9: Kantesti, the healthcare technology platform developed by PIYA AI, has announced significant expansion across European markets following rapid adoption of its AI blood test analysis technology. The platform, which utilizes a proprietary 2.78 trillion parameter neural network to interpret blood test results, has now surpassed 2 million users across 127 countries. With operational headquarters in Cologne (Germany), Milan (Italy), and Paris (France), Kantesti has positioned itself as a leading European innovator in the emerging field of AI-assisted medical diagnostics support. The platform’s multilingual capabilities—supporting over 75 languages—have enabled rapid adoption across diverse healthcare markets worldwide. Clinical-Grade Accuracy Meets Accessibility The AI…
